604 |
Cytokine-cytokine receptor interaction |
6 |
1.29e−18
|
Ccl11; Ccl2; Ccl5; Ccl7; Ccl8; Ccl9; Ccr10; Cxcl10; Cxcl9; Cxcr2; Cxcr5; Il13ra1; Il18; Il2rb |
4351 |
Chemokine signaling pathway |
6 |
9.54e−15
|
Ccl11; Ccl2; Ccl5; Ccl7; Ccl8; Ccl9; Ccr10; Cxcl10; Cxcl9; Cxcr2; Cxcr5 |
8111 |
NOD-like receptor signaling pathway |
11 |
3.41e−11
|
Casp1; Ccl11; Ccl2; Ccl5; Ccl7; Ccl8; Il18 |
8116 |
Cytosolic DNA-sensing pathway |
7 |
6.15e−6
|
Casp1; Ccl5; Cxcl10; Il18 |
11853 |
Chemokine receptors bind chemokines |
14 |
1.53e−5
|
Ccl5; Ccr10; Cxcr2 |
9938 |
Cytokine receptor degradation signaling (JAK-STAT pathway and regulation pathway) |
9 |
5.33e−5
|
Cxcr2; Il13ra1; Il2rb |
9526 |
Negative regulation of phosphorylation of the cytokine receptor in the JAK-STAT pathway (JAK-STAT pathway and regulation pathway) |
9 |
5.33e−5
|
Cxcr2; Il13ra1; Il2rb |
9644 |
Negative feedback regulation of the JAK-STAT pathway by cytokine receptor degradation signaling (JAK-STAT pathway and regulation pathway) |
8 |
8.86e−5
|
Cxcr2; Il13ra1; Il2rb |
10373 |
Malaria |
6 |
0.00018 |
Ccl2; Il18; Itgb2 |
699 |
Toll-like receptor signaling pathway |
3 |
0.00143 |
Ccl5; Cxcl10; Cxcl9 |
10401 |
Chagas disease (American trypanosomiasis) |
3 |
0.00152 |
C3; Ccl2; Ccl5 |
10320 |
JAK-STAT pathway and regulation pathway |
2 |
0.00157 |
Cxcr2; Il13ra1; Il18; Il2rb |
10352 |
Staphylococcus aureus infection |
4 |
0.00575 |
C3; Itgb2 |
11557 |
Immunoregulatory interactions between a lymphoid cell and a nonlymphoid cell |
3 |
0.00767 |
C3; Itgb2 |
10360 |
Leishmaniasis |
3 |
0.00928 |
C3; Itgb2 |
651 |
JAK-STAT signaling pathway |
1 |
0.04584 |
Il13ra1; Il2rb |